Equity Research on Most Popular Searches: Cognizant, Vertex, Wells Fargo, America Movil, Lowe's, and Halliburton
VANCOUVER, British Columbia, May 8, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Cognizant (NASDAQ:CTSH), Vertex (NASDAQ:VRTX), Wells Fargo (NYSE:WFC), America Movil (NYSE:AMX), Lowe's (NYSE:LOW), and Halliburton (NYSE:HAL).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Cognizant Technology Solutions Corp (NASDAQ:CTSH): Cognizant Technology Solutions Corp (NASDAQ:CTSH) reported its revenue for first quarter 2012 jumped by 24.8% to US$1.71 billion, from US$1.37 billion in the same quarter last year. GAAP net income was US$243.7 million, or US$0.79 per diluted share. That was compared with GAAP net income of US$208.3 million, or US$0.67 per diluted share, a year ago. Abnormal trading volume of Cognizant was found on May 7 reaching 38.06 million shares, 17.8 times heavier than usual day trading. The stock sharply plunged 19.18% to US$56.30. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in CTSH are starting to buy more company shares. See insider trade report for CTSH here.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX): Insiderslab.com found Market Option Sale (Planned) made by company Director -- Boger Joshua S on May 2, at stock price US$38.39. Disclose date: May 4. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) began the trading session with a price of US$26.84 and throughout the session climbed to a high of US$28.47. When day-trade ended, the stock finally advanced 4.47% to US$28.25. The stock has been moving within a range of US$20.65 - US$28.47 over the past 52 weeks. There were 11.60 million shares of Vertex exchanging hands as compared to its average daily volume of 5.28. Since insiders such as CEOs, CFOs and Directors have better access to company non-public information, Insiderslab.com thinks that investors would be wise to pay close attention to their stock trading behaviors. Check this insider trade report for VRTX here.
Wells Fargo & Company (NYSE:WFC): Insiderslab.com found Market Option Sale made by company Senior Executive Vice President, Wealth, Brokerage and Retirement Services -- David M. Carroll on April 27, at stock price US$33.89. Disclose date: April 30. Wells Fargo & Company (NYSE:WFC) announced on Monday that the company had 749,806 active trial or completed mortgage modifications in place through March 2012. Wells Fargo Insurance, a unit of Wells Fargo & Company, has recently appointed Suzanne O'Keefe as Senior Vice President and Managing Director for its Raleigh N.C., Greensboro, N.C. and Charleston, S.C. offices. In addition, Michael B. Murray was appointed as Senior Vice President and Managing Director for its Charlotte, N.C. operations, as well as operations in Winston Salem, N.C. and Greenville and Columbia, S.C. Wells Fargo has a market capitalization of 177.60 billion. The stock closed higher by 1.42% to US$33.50 with more than 28.21 million shares traded, compared to its average volume of 25.56 million shares. Academic studies have shown that insiders traditionally make higher investment returns than ordinary investors. Want to find out how they do it?
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Important Disclaimer: Please visit insiderslab.com/disclaimers/disclaimers.php for details.